JPMorgan raises its stake in Chinese securities business to 71%
Category: #business  | By Nikita Chaurasia  | Date: 2020-11-03 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

JPMorgan raises its stake in Chinese securities business to 71%

JPMorgan Chase & Co., a U.S.-based multinational investment bank and financial services provider, has reportedly raised its stake in a Chinese securities business to secure 71% stocks. Sources with knowledge of the matter stated that the bank recently purchased an additional 20% stake which was put up for sale by Shanghai Waigaoqiao FTZ for USD 26.6 million (177.7 million yuan).

The recent development comes just before the November 3 presidential elections, with geopolitical tensions between China and the United States remain fragile.

In fact, the move has allowed JPMorgan to become the first foreign bank to attain complete ownership of a Chinese firm, as the country resumes its financial market worth USD 50 trillion, sources claimed. However, a spokesperson from JP Morgan declined to comment on the recent development.

If reports are to be believed, JPMorgan was the only bank that could increase its ownership stake with priority rights in the China-based securities joint venture. The remaining four shareholders had given up their rights to acquire 20% stake.

It is to be noted that the securities joint venture comprises of fixed income businesses, research, and other operations related to investment banking. In this context, sources confirmed that JPMorgan is planning to hire around 12 equity research analysts, in its first major mainland China hiring process.

For those uninitiated, after decades of only allowing foreign banks to own minority stake, Beijing recently gave a green light to European and Wall Street banks to take complete ownership of various businesses in China. This will apparently allow the banks to better strategize to enter China’s vast financial market.

Other banking institutions such as Goldman Sachs, Morgan Stanley, and UBS Group, who currently hold 51% stake in Chinese firms, are also investing millions in an effort to expand their reach in the world’s most populous economy.

Source Credits –

https://www.reuters.com/article/us-jpmorgan-china/jpmorgan-takes-71-in-china-securities-business-idUSKBN27I0AZ

https://www.bloombergquint.com/business/jpmorgan-raises-stake-in-china-securities-venture-to-71

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...